Global Home Infusion Therapy Market Overview

The Global Home Infusion Therapy Market size is expected to grow from USD 22.98 billion in 2023 to USD 40.92 billion by 2032, at a CAGR of 6.62% during the forecast period (2024-2032).

Home infusion therapy is a rapidly growing segment within the healthcare industry, providing patients with the convenience and comfort of receiving intravenous medications or fluids in their own homes rather than in a hospital or clinic setting. This form of treatment is typically used for patients requiring long-term care for conditions such as infections, immune deficiencies, dehydration, chemotherapy, and pain management. The therapy involves skilled healthcare professionals administering medications through various infusion methods, ensuring patients receive proper dosage and monitoring.

The industry has seen significant expansion due to several factors. Firstly, an aging population with complex medical needs prefers home-based care for its comfort and reduced risk of hospital-acquired infections. Secondly, advancements in medical technology and infusion devices have made it easier and safer to administer treatments outside of traditional healthcare settings. Moreover, healthcare policies and reimbursement structures increasingly favor home infusion therapy as a cost-effective alternative to hospital stays, promoting its adoption among healthcare providers and insurers.

Key stakeholders in the home infusion therapy industry include specialized pharmacies, home healthcare providers, infusion nurses, and medical equipment suppliers. These entities collaborate closely to ensure seamless delivery of care, from prescribing medications to monitoring patient outcomes. Regulatory bodies such as the Centers for Medicare & Medicaid Services (CMS) and accreditation organizations set standards to ensure quality and safety in home infusion services, further driving the professionalism and reliability of providers in the industry.

Market Dynamics and Key Factors of Home Infusion Therapy:

Drivers:

Hospital-Like Care at Home
Patients can receive an innovative and comprehensive set of services with a variety of care alternatives when they choose home infusion services. Home services can help patients to avoid extended hospital stays and high medical fees by providing care in the comfort of the home. Individuals can receive IV infusions in a comfortable and safe atmosphere as part of several infusion therapies. With the guidance of a trustworthy health provider, a patient recovering from surgery or undergoing surgery therapy can access a variety of home care infusion services. Professionals can assist patients with all types of infusions, from the first interaction with the client to providing professional home therapy.

To reduce the strain on the primary healthcare services
The market is expected to grow in response to the growing need to shorten inpatient stays. According to the American Hospital Association, there were approximately 36,241,815 hospital admissions in all US hospitals in 2019. This has prompted the development of ways for administering infusion therapy at home or in other healthcare settings, which is expected to boost the market growth. While hospitals have quickly adopted smart infusion pumps with useful features like EHR connection, drug libraries, and medication safety software, most home infusion providers still use classic infusion pumps. However, due to rising demand, there has been a growing trend for equipment upgrades, particularly in developed countries thus, supporting the development of the home infusion therapy market over the forecast period.

Restraints:

Third-Party service providers and low reimbursement policies

The issue of fragmented care may develop in the home infusion setting if the home infusion provider is a third-party company that is not part of the patient's primary care team. Concerns about the patient's limited access to their care team may also cause issues, as eliminating the requirement for patients to visit the clinic for each infusion reduces their interaction with their provider. Other issues that may develop include the patient's potential limited access to emergency services if a negative reaction or adverse event (AE) occurs during the infusion thus, hampering the growth of the market over the projected timeframe.

Opportunities:

Growing Geriatric Population
According to the United Nations, the world's population will grow by one billion people by 2025, with roughly a third of them being 65 or older as life expectancy rises. Middle-class comforts and urbanization are also on the rise, potentially leading to more sedentary lifestyles and chronic illnesses. There is concern that all of this will place a further strain on the global health system's ability to administer and pay for care. As a result, there has been a significant shift in healthcare toward a more patient-centered, community-based approach. Regulations in the healthcare industry have supported the growth of the home infusion therapy market. For instance, healthcare systems in the USA are implementing new guidelines to support home infusion therapies thus, creating a lucrative opportunity for the market players.

Market Segmentation

By product type, the infusion pump segment is anticipated to have the highest share of the home infusion therapy market. It is projected to record a 5.4% CAGR and reach USD 18.2 billion by the end of the analysis period. Infusion pumps have numerous benefits over manual fluid administration, including the ability to give fluids in very small quantities and at precisely programmed rates or automatic intervals. They can be utilized to administer nutrients or pharmaceuticals like insulin or other hormones, antibiotics, chemotherapeutic treatments, and pain relievers. Large volume, patient-controlled analgesia (PCA), elastomeric, syringe, enteral, and insulin pumps are among the various types of infusion pumps available.

By infusion type, the continuous segment is estimated to dominate the infusion therapy market. Continuous infusion maintains a constant concentration of microbubbles, lowering the risk of artifacts. If there is a steady-state concentration of contrast, it is also possible to compute myocardial blood flow, as both myocardial blood volume and microbubble velocity can be calculated. Continuous infusion strategies have been found in studies to be the best options for drug administration in cancer patients thus, supporting the growth of the segment.

By application, the anti-infective segment is anticipated to lead the growth of the home infusion therapy market. One of the most regularly prescribed home infusion therapies is anti-infective therapy (antibiotics, antifungals, and antivirals), which can be safely managed at home. Cystic fibrosis, Lyme disease, Osteomyelitis, and other infections that require long-term anti-infective therapy can all be caused by a variety of causes. If not treated properly, each of these clinical disorders can lead to unnecessary hospitalization and/or emergency room visits. These disorders can be treated at home using infusion therapy, which can help avert life-threatening situations thus, boosting the development of the segment.

Players Covered in Home Infusion Therapy market are :

• CVS/Coram
• Option Care Health
• BriovaRx/Diplomat (UnitedHealth Optum)
• PharMerica
• Fresenius Kabi
• ICU Medical Inc.
• B. Braun Melsungen AG
• Baxter
• BD
• Caesarea Medical Electronics
• Smiths Medical
• Terumo Corporation
• JMS Co. Ltd and others major players.

Regional Analysis of Home Infusion Therapy Market:

In North America, particularly in the United States and Canada, the home infusion therapy market is well-established and growing steadily. Factors driving this growth include a large elderly population with chronic conditions, favorable reimbursement policies from Medicare and private insurers, and advanced healthcare infrastructure supporting home-based care. The region also benefits from a robust network of specialty pharmacies and home healthcare providers offering comprehensive infusion services, coupled with stringent regulatory standards ensuring patient safety and quality of care.

In Europe, the home infusion therapy sector is expanding as healthcare systems increasingly prioritize cost-effective care delivery and patient-centered services. Countries like the United Kingdom, Germany, and France lead in adopting home-based infusion therapies, driven by aging populations and a shift towards reducing hospital admissions. Regulatory harmonization across the European Union facilitates cross-border collaboration among healthcare providers and promotes standardization of care practices.

Overall, regional variations in healthcare systems, regulatory environments, economic conditions, and patient preferences shape the development and adoption of home infusion therapy globally. As the industry continues to evolve, stakeholders must navigate these diverse landscapes to capitalize on opportunities and address challenges in delivering quality, accessible care to patients in their homes.

Recent Industry Developments in Home Infusion Therapy Market

• In January 2024, BrightStar Care collaborated with Paragon Healthcare to offer high-quality home infusion services. This strategic collaboration enables Paragon Healthcare to efficiently enhance the delivery of high-quality home infusion services to a broader clientele through BrightStar Care's nurse-led, Joint Commission-accredited care model.

• In January 2023, KORU Medical Systems, Inc. has partnered with a pharmaceutical manufacturer to develop and approve the Freedom Infusion System, which uses a prefilled syringe for subcutaneous immunoglobulin therapy (SCIg). The system includes Freddom60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets for home and alternate care settings.